1 / 3

Tuberculosis Pipeline Landscape and Therapeutics Market Review for H2 2016

Tuberculosis, commonly known as TB, is a bacterial infection that can spread through the lymph nodes and bloodstream to any organ in body. It is most often found in the lungs. The symptoms of tuberculosis range from no symptoms (latent tuberculosis) to symptoms of active disease. Symptoms include overall sensation of feeling unwell; cough, possibly with bloody mucus, fatigue, shortness of breath, weight loss and pain in the chest. Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Tuberculosis Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Tuberculosis (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

Download Presentation

Tuberculosis Pipeline Landscape and Therapeutics Market Review for H2 2016

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Tuberculosis Pipe Tuberculosis Pipeline Landscape and Therapeutics line Landscape and Therapeutics Market Market Review for H2 2016 Review for H2 2016 N N N No o o o o o o of f f f P P P Pa a a ag g g ge e e es s s s – – 3 39 93 3 P P P Pu u u ub b b bl l l li i i is s s sh h h hi i i in n n ng g g g D D D Da a a at t t te e e e - - N No ov ve em mb be er r, , 2 20 01 16 6 B B B Br r r ro o o ow w w ws s s se e e e d d d de e e et t t ta a a ai i i il l l le e e ed d d d T T T TO O O OC C C C, , , , T T T Ta a a ab b b bl l l le e e es s s s, , , , F F F Fi i i ig g g gu u u ur r r re e e es s s s, , , , a a a an n n nd d d d C C C Ch h h ha a a ar r r rt t t ts s s s i i i in n n n G G G Gl l l lo o o ob b b ba a a al l l l S S S Se e e er r r ri i i ia a a al l l l D D D De e e ev v v vi i i ic c c ce e e e S S S Se e e er r r rv v v ve e e er r r r C C C Co o o on n n ns s s su u u um m m mp p p pt t t ti i i io o o on n n n 2 2 2 20 0 0 01 1 1 16 6 6 6 M M M Ma a a ar r r rk k k ke e e et t t t R R R Re e e es s s se e e ea a a ar r r rc c c ch h h h R R R Re e e ep p p po o o or r r rt t t t a a a at t t t: : : : http://www.marketresearchhub.com/report/tuberculosis-pipeline-review-h2-2016- report.html Tuberculosis, commonly known as TB, is a bacterial infection that can spread through the lymph nodes and bloodstream to any organ in body. It is most often found in the lungs. The symptoms of tuberculosis range from no symptoms (latent tuberculosis) to symptoms of active disease. Symptoms include overall sensation of feeling unwell; cough, possibly with bloody mucus, fatigue, shortness of breath, weight loss and pain in the chest. Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide T Tuberculosis Pipeline Review uberculosis Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Tuberculosis (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

  2. T T T Ta a a ab b b bl l l le e e e o o o of f f f C C C Co o o on n n nt t t te e e en n n nt t t ts s s s Introduction 7 Tuberculosis Overview 8 Therapeutics Development 9 Tuberculosis - Therapeutics under Development by Companies 11 Tuberculosis - Therapeutics under Investigation by Universities/Institutes 16 Tuberculosis - Pipeline Products Glance 19 Tuberculosis - Products under Development by Companies 23 Tuberculosis - Products under Investigation by Universities/Institutes 30 Tuberculosis - Companies Involved in Therapeutics Development 35 Tuberculosis - Therapeutics Assessment 99 Drug Profiles 111 Tuberculosis - Dormant Projects 345 Tuberculosis - Discontinued Products 356 Tuberculosis - Product Development Milestones 357 Appendix 371 List of Tables Number of Products under Development for Tuberculosis, H2 2016 30 Number of Products under Development for Tuberculosis - Comparative Analysis, H2 2016 31 Number of Products under Development by Companies, H2 2016 32 Number of Products under Development by Companies, H2 2016 (Contd..1) 33 Number of Products under Development by Companies, H2 2016 (Contd..2) 34 Number of Products under Development by Companies, H2 2016 (Contd..3) 35 Number of Products under Development by Companies, H2 2016 (Contd..4) 36 Number of Products under Investigation by Universities/Institutes, H2 2016 37 Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 38 Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..2) 39 Comparative Analysis by Late Stage Development, H2 2016 40 Comparative Analysis by Clinical Stage Development, H2 2016 41 Comparative Analysis by Early Stage Development, H2 2016 42 Comparative Analysis by Unknown Stage Development, H2 2016 43 List of Figures Number of Products under Development for Tuberculosis, H2 2016 30 Number of Products under Development for Tuberculosis - Comparative Analysis, H2 2016 31 Number of Products under Development by Companies, H2 2016 32 Number of Products under Investigation by Universities/Institutes, H2 2016 37 Request for Free Sample Report

  3. Comparative Analysis by Late Stage Development, H2 2016 40 Comparative Analysis by Clinical Stage Development, H2 2016 41 Comparative Analysis by Early Stage Products, H2 2016 42 Assessment by Monotherapy Products, H2 2016 120 Assessment by Combination Products, H2 2016 121 R R R Re e e ep p p po o o or r r rt t t t D D D De e e et t t ta a a ai i i il l l ls s s s – – D D D Da a a at t t te e e e o o o of f f f P P P Pu u u ub b b bl l l li i i is s s sh h h hi i i in n n ng g g g – – N No ov ve em mb be er r, , 2 20 01 16 6 N N N No o o o o o o of f f f P P P Pa a a ag g g ge e e es s s s – – 3 39 93 3 S S S Si i i in n n ng g g gl l l le e e e U U U Us s s se e e er r r r L L L Li i i ic c c ce e e en n n ns s s se e e e – – $ $2 20 00 00 0 M M M Mu u u ul l l lt t t ti i i ip p p pl l l le e e e U U U Us s s se e e er r r r L L L Li i i ic c c ce e e en n n ns s s se e e e – – $ $4 40 00 00 0 A A A Ab b b bo o o ou u u ut t t t M M M Ma a a ar r r rk k k ke e e et t t t R R R Re e e es s s se e e ea a a ar r r rc c c ch h h h H H H HU U U UB B B B : : : : M Ma ar rk ke et t R Re es se ea ar rc ch h H HU UB B i is s t th he e c cr re ed di ib bl le e s so ou ur rc ce e f fo or r g ga ai in ni in ng g t th he e m ma ar rk ke et t r re es se ea ar rc ch h r re ep po or rt ts s t th ha at t w wi il ll l e ex xp po on ne en nt ti ia al ll ly y a ac cc ce el le er ra at te e y yo ou ur r b bu us si in ne es ss s. . W l le ea ad di in ng g r re ep po or rt t r re es se el ll le er rs s i in n t th he e b bu us si in ne es ss s w wo or rl ld d c co om mm mi it tt te ed d t to ow wa ar rd ds s o op pt ti im mi iz zi in ng g y yo ou ur r b bu us si in ne es ss s. . T Th he e r re ep po or rt ts s w we e p pr ro ov vi id de e a ar re e b ba as se ed d o on n a a r re es se ea ar rc ch h t th ha at t c co ov ve er rs s a a m ma ag gn ni it tu ud de e o of f f fa ac ct to or rs s s su uc ch h a as s t te ec ch hn no ol lo og gi ic ca al l e ev vo ol lu ut ti io on n, , e ec co on no om mi ic c s sh hi if ft ts s a an nd d a a d de et ta ai il le ed d s st tu ud dy y o of f m ma ar rk ke et t s se eg gm me en nt ts s. . C C C Co o o on n n nt t t ta a a ac c c ct t t t– – – – 90 State 90 State Street, Street, Albany, NY 12207, Albany, NY 12207, United States United States Toll Free : 866 Toll Free : 866- -997 997- -4948 (US 4948 (US- -Canada) Canada) Tel : +1 Tel : +1- -518 518- -621 621- -2074 2074 Email : Email : mailto:sales@marketresearchhub.com mailto:sales@marketresearchhub.com Website : Website : http://www.marketresearchhub.com/ http://www.marketresearchhub.com/ Buy Report Now! We e a ar re e a am mo on ng g t th he e

More Related